Catalyst Crew Technologies Corp. (OTC: CCTC) has taken a significant step in its corporate rebranding by submitting a corporate action request to the Financial Industry Regulatory Authority (FINRA) for approval of a proposed name change to LataMed AI Corp. and a corresponding trading symbol change. The announcement, made on March 20, 2026, underscores the company's strategic transition toward artificial intelligence-enabled healthcare technology, with an initial focus on Latin America.
The proposed name change, approved by the company's Board of Directors and majority shareholder, is designed to align the company's public identity with its new strategic direction. The company emphasized that the corporate action does not involve any reverse stock split, forward stock split, recapitalization, or changes to its capital structure. The issued and outstanding share count will remain unchanged, meaning shareholders' ownership interests will not be affected, and no action is required from existing shareholders.
Upon FINRA approval, Catalyst Crew Technologies intends to file a Certificate of Amendment with the Nevada Secretary of State to formalize the name change. The new name and symbol would become effective after the completion of required corporate filings and publication by FINRA on the Daily List.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated, "There is no change to the Company’s capital structure as part of this process. This proposed name change is intended to better align the Company’s public identity with its healthcare technology strategy and long-term market focus."
The company, which describes itself as an artificial intelligence-driven healthcare technology company, is actively developing scalable digital health solutions for emerging markets. Its strategic initiatives include telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. These efforts are aimed at improving access, efficiency, and care coordination in regions with growing demand for modernized healthcare delivery systems.
Catalyst Crew Technologies is a development-stage enterprise and has not yet generated revenues from its newly announced business direction. The company acknowledged that there is no assurance FINRA will approve the name change or the requested new trading symbol, or the timing of any such approval.
For more information, interested parties can visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
